In uncertain market phases, products offering capital protection are particularly sought after. The capital protection certificate on Alcon, Kühne + Nagel and Sika offers a minimum repayment of 96% at maturity. In addition, investors participate in the positive performance of the underlying.

Since Donald Trump's re-election as US President, the outlook for the global healthcare sector has deteriorated. In this environment, investment instruments that offer both a safety net and attractive yield opportunities are in demand. With the ZKB bonus certificate on five Swiss pharmaceutical stocks, investors participate in the potential of the underlying securities without being fully exposed to market fluctuations.

European insurers have outperformed the stock market year-to-date. Due to their stable business model, they are considered to be reliable dividend payers, making their shares an ideal underlying for yield enhancement products.

German mid caps are in demand. However, there are considerable performance differences among MDax members since the beginning of the year.

The IPO of Holcim's North American business is on track and is expected to take place in June. Meanwhile, industrial companies ABB and OC Oerlikon are also offloading business dividisions to sharpen their profiles.

Wall Street has recovered from the losses triggered in early April by the turmoil surrounding US tariff policy. However, some technology giants are still trading well below the levels they reached before the market correction.

Global equity markets have started the year at different speeds. Barrier reverse convertibles on the SMI, EuroStoxx 50 and S&P 500 offer diversification across regions and sectors.

Global financial markets have calmed down somewhat this week and the Swiss equity index SMI is on track for a weekly gain. However, the impact of the recent market turmoil on individual stocks varies considerably.

Learn, trade and succeed: Expand your financial knowledge and test your trading strategies with the educational game on structured products.

The import tariffs imposed by US President Donald Trump have led to a global slump in share prices. Swiss companies that do little business in the US are less likely to feel the immediate impact of the tariff hikes.